Cerebrovascular Disease, Certification and Peripheral Arterial Disease

CorVascular’s VasoGuard Earns FDA 510(k) Clearance

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:16 July 29, 2024 — CorVascular , a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) testing devices, today announced the U.S. Food and Drug Administration (FDA) has cleared its VasoGuard V-Series as Class II medical devices.

Certification

Certification Peripheral Arterial Disease Cerebrovascular Disease Quality of Life

Cardiovascular Update

CorVascular’s VasoGuard Earns FDA 510(k) Clearance

Webinars

Stay Connected